维普中文期刊产品整合服务
9篇 您的检索式:作者名="Puccini B"
    题名 作者 年代 出处 被引量
1Allogeneic hem- atopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study 显示文摘Rigacci L Puccini B Dodero A 2012Ann Hematol2012,91,6:1
2Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study显示文摘Rigacci L Puccini B Dodero AP 2012Ann Hematol2012,91,6:1
3Oxaliplatin-based ehemo- therapy(dexamethasone, high-dose eytarabine, and oxaliplatin) rituximab is an effective salvage regimen in patients with relapsed or refractory lymphoma显示文摘Rigacci L Fabbri A Puccini B 2010Cancer2010,116,19:1
4Allogeneic hemato- poietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study 显示文摘Rigacci L Puccini B Dodero AP 2012Ann Hematol2012,91,6:1
5The effects of thoracic epidural anesthesia on hepatic perfusion and oxygenation in healthy pigs during general anesthesia and surgical stress显示文摘VAGST D A IBER T PUCCINI M SZABO B 2003Anesth Analg2003,97,6:1
6Preoperative mapping of speech-eloquent areas with functional magnetic resonance imaging (fMRI):comparison of different task designs显示文摘PROTHMANN S PUCCINI S DALITZ B 2005Rofo2005,177,11:1
7Primary lympboma of bone:outcome and role of surgery显示文摘Scoccianti G Rigacci L Puccini B 0,,12:1
8Oxaliplatin-based chemotherapy (dexamethasone,high-dose cytarabine,and oxaliplatin) ± rituximab is an effective salvage regimen in patients with relapsed or refractory lymphoma显示文摘Rigacci L Fabbri A Puccini B 2010Cancer2010,116,19:1
9Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation:A GITMO study显示文摘Rigacci L Puccini B Dodero A 0,,06:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费